New family of cancer genes discovered

Introgen Therapeutics, Inc. (NASDAQ: INGN) has licensed a group of newly discovered and sequenced genes that appear to play a critical role in suppressing and preventing the development of lung and other cancers. This family of genes includes at least 10 members. Discovery of these tumor suppressor genes represents a joint collaborative effort by The University of Texas Southwestern Medical Center, The University of Texas M. D. Anderson Cancer Center, and the National Cancer Institute.

Contact:
C. Channing Burke
c.burke@introgen.com
512-708-9310
Porter Novelli

Message posted by: Wouter Kalle